MeSH tree: C23.550.291.656
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given before surgery for patients with high-risk, early-stage HER2-negative breast cancer, according to Phase II clinical ...
Jul 30, 2026
0
10
Australian researchers have found a new biomarker for multiple myeloma that could help doctors rapidly identify patients at greatest risk of poor outcomes, enabling more personalized and effective treatments. Multiple myeloma ...
Jul 21, 2026
0
7
Disease progression in people with Parkinson's disease can be accurately monitored using sensors, removing some of the limitations of wearable technologies, a new study reports. In the study published in the Journal of NeuroEngineering ...
Jul 13, 2026
0
6
Researchers at Lund University have developed a blood test capable of detecting signs of breast cancer recurrence long before recurrence becomes visible on imaging or causes symptoms. It has previously been shown that this ...
May 26, 2026
0
10
Thanks to improved treatments, many people with asthma live good lives. However, for a smaller group—those with severe asthma—the picture is different. A new study within the Nordic research collaboration NORDSTAR, based ...
May 4, 2026
0
6
Fragments of tumor DNA circulating in the bloodstream of patients with breast cancer can predict whether they are likely to relapse, especially when samples are taken after the patients have received treatments prior to surgery. ...
Mar 26, 2026
0
9
For patients requiring urgent and emergent surgery, bypassing the nearest surgical hospital (NSH) is associated with worse clinical outcomes, according to a study published online Feb. 18 in the Journal of the American College ...
Feb 26, 2026
0
4
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer after they received neoadjuvant treatment and surgery predicted worse outcomes than in ...
Jan 14, 2026
0
12
Despite modern imaging and genetic testing, diagnosing amyotrophic lateral sclerosis (ALS) remains challenging, particularly when distinguishing it from clinically similar neurodegenerative disorders.
Oct 29, 2025
0
12
The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.
Sep 11, 2025
0
19
